BIOCON Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > biocon

Technical Analysis

Technical Strength: 6.2 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 52.5. According to RSI analysis, biocon is technically strong. 9.0 BIOCON RSI Chart
MACD (?) MACD: 3.77 and Signal Line: 4.8. According to MACD analysis, biocon is marginally weak. 3.0 BIOCON MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, biocon is in a strong uptrend. Major support levels are 255.1425, 243.796, 199.9114. 6.0 BIOCON Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, biocon is in a strong uptrend. Major support levels are 255.4076, 246.7664, 211.2367. 6.0 BIOCON Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.525. 5.0 BIOCON Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 254.375 and 250.0739. Resistance level is 258.6761. 8.0 BIOCON Fibonacci Retracement Chart
Average True Range (?) ATR: 8.28 NA BIOCON Average True Range Chart
Average Directional Index (?) ADX is 25.6 which means BIOCON is in a trend. NA BIOCON Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 22, 2019
Open Price 255.5
High Price 258.25
Low Price 252.5
Close Price 255.9
Absolute Change 1.55
Percentage Change 0.609%
Weekly Change -0.525%
Monthly Change 4.43%
Yearly Change 63.5%
52-week high 272.6
52-week low 127.125
Corporate Actions
ExDate Purpose
July 18, 2019 DIV - RS 0.50 PER SH
July 18, 2019 DIV - RE 1 PER SH
June 12, 2019 BONUS 1:1
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.75
Confidence in Beta4.09%
Market Capital Rs. 5117.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 22 November 2019: Deliverable Quantity:7.58e+05 NA BIOCON Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 22 November 2019: Daily Volatility:0.3993 NA BIOCON Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 22 November 2019: PCR_OI:0.184 PCR:0.163 NA BIOCON PCR Chart
Option Pain (?) 22 November 2019: Max Pain:260.0 NA BIOCON Option Pain Chart
Premium (?) 22 November 2019 Premium: 0.45 Futures OI:9855000.0 NA BIOCON Premium Chart
Option_MAX_OI (?) 22 November 2019: Price:255.9 Put with maximum OI:240.0 Call with maximum OI:270.0 NA BIOCON Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 28, 2019 256.35 9855000.0 1603.0 1603.0 255.9
December 26, 2019 256.95 2190600.0 735.0 735.0 255.9
January 30, 2020 256.85 225400.0 4.0 4.0 255.9

Announcements

November 07, 2019 Reply to Clarification Sought BIOCON: The Exchange had sought clarification from Biocon Limited with respect to announcement dated 23-Oct-2019, regarding change in Director(s) of the company. On basis of above the Company was required to clarify following: 1. Confirmation from resigning independent director that there is no other material reasons other than provided. The response of the Company is attached.
November 07, 2019 Clarification BIOCON: The Exchange has sought clarification from Biocon Limited with respect to announcement dated 23-Oct-2019, regarding change in Director(s) of the company. On basis of above the Company is required to clarify following: 1. Confirmation from resigning independent director that there is no other material reasons other than provided. The response of the Company is awaited.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 04, 2019 October 23, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
July 04, 2019 July 25, 2019 Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters
See all Board Meetings

BIOCON is part of...

Index Weightage
CNXPHARMA NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play